نتایج جستجو برای: naftopidil

تعداد نتایج: 104  

Journal: :Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 1991

2017
Wei Xu Junjun Huang Renwang Jiang Mu Yuan

Chiral drug naftopidil (NAF), a specific α1D-adrenoceptor (AR) antagonist for the treatment of benign prostatic hyperplasia, was used in racemic form for several decades. Our recent work declared that NAF enantiomers showed the same antagonistic effects on the α1D-AR, but the binding mechanism of these two stereochemical NAF isomers to the α1D receptor remained unclear. Herein, we reported the ...

2011
Igarashi Ito Okawa Sakuma Sato

Hypothesis / aims of study Alpha-1 blockers are the first option for the medical treatment of benign prostatic hyperplasia (BPH), and differ in their likelihood of causing abnormal ejaculation and sexual dysfunction, depending on their affinity of alpha-1 adrenoceptor subtypes. A new alpha-1 blocker, silodosin is 162 times more selective for alpha-1A than for alpha-1B, and is approximately 55 t...

Journal: :Molecules 2014
Tomoyuki Nishizaki Takeshi Kanno Ayako Tsuchiya Yoshiko Kaku Tadashi Shimizu Akito Tanaka

We have originally synthesized the naftopidil analogue 1-[2-(2-methoxyphenylamino)ethylamino]-3-(naphthalene-1-yloxy)propan-2-ol (HUHS 1015) as a new anticancer drug. HUHS1015 induces cell death in a wide variety of human cancer cell lines originated from malignant pleural mesothelioma, lung cancer, hepatoma, gastric cancer, colorectal cancer, bladder cancer, prostate cancer, and renal cancer. ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید